Abstract
The effect of chronic 5 alpha-pregnane-3 alpha-ol-20-one (5 alpha 3 alpha; neurosteroid) treatment was investigated on the gamma-aminobutyric acid (GABA), 5 alpha 3 alpha, and ligands that bind to the benzodiazepine (BZ) site on GABA-induced [36Cl-]influx in intact cultured mammalian cortical neurons. Chronic 5 alpha 3 alpha treatment (1 microM; 5 days) decreased the efficacy of GABA, because its Emax (maximal response) value was decreased, whereas the EC50 (potency) value was not altered. Chronic 5 alpha 3 alpha treatment also decreased the Emax value of BZ agonists like diazepam to potentiate GABA-induced [36Cl-] influx, and decreased the -Emax (maximal inhibitory response) value of inverse agonists like methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3'-carboxylate to inhibit GABA-induced [36Cl-] influx, whereas not altering their EC50/IC50 values. Furthermore, chronic 5 alpha 3 alpha treatment decreased the Emax value of 5 alpha 3 alpha to potentiate GABA-induced [36Cl-] influx, without altering its EC50 value. The decreased efficacy of GABA and 5 alpha 3 alpha were reversed by concomitant exposure of the neurons to R 5135 (3 alpha-hydroxy-16-imino-5 beta-17-androstan-11-one; a competitive GABA antagonist). Taken together, these findings suggest that chronic 5 alpha 3 alpha treatment produces decreased efficacy of GABA, ligands that bind to the BZ site, and neurosteroids at the GABAA-BZ receptor complex. The decreased efficacy is heterologous in nature and involves mediation via the GABAA receptor site.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|